Exit: Halder sells Klingel medical metal to IK Investment Partners

Pforzheim/ Frank­furt — Halder Betei­li­gungs­be­ra­tung GmbH has ente­red into an agree­ment to sell Klin­gel medi­cal metal, Pforz­heim, to IK Invest­ment Part­ners. Klin­gel has been a Halder invest­ment since 2012, and the finan­cial details of the tran­sac­tion were not disclosed.

Klin­gel medi­cal metal was foun­ded in 1986 and manu­fac­tures complex precis­ion parts from diffi­­cult-to-machine mate­ri­als such as stain­less steel and tita­nium. In 2012, sales amoun­ted to €23.6 million, of which around 50% was attri­bu­ta­ble to custo­mers in the medi­cal tech­no­logy sector. Since then, Klin­gel has deve­lo­ped into a successful supplier for medi­cal tech­no­logy by focu­sing its busi­ness model, compre­hen­sive rebran­ding and inten­sive market deve­lo­p­ment. The new stra­te­gic alignment was supported by invest­ments of around €15 million for capa­city expan­sion and the exten­sion of the value chain to include proto­type produc­tion, highly auto­ma­ted clea­ning and elec­tro­po­li­shing. By the end of 2017, busi­ness volume had increased by around 55% to €36.5 million as a result of orga­nic growth and the acqui­si­tion of Josef Ganter Fein­me­cha­nik in 2016. In paral­lel, the share of sales accoun­ted for by medi­cal tech­no­logy increased to around 70%. The number of employees increased from around 200 to over 300 in the same period.

Parties invol­ved Halder
Halder: Michael Wahl, Chris­tian Muschalik
Seller finan­cial advi­sor: William Blair (Phil­ipp Mohr, Moritz Rottwinkel)
Seller legal advi­sor: Graf von West­fa­len (Lutz Zimmer, Ernst Lindl)

About Halder
Halder has been active as an equity inves­tor in Germany since 1991 and has provi­ded equity capi­tal for succes­sion and growth to 38 medium-sized compa­nies. The sale of Klin­gel is the second exit from the port­fo­lio of the Halder Germany II fund. Halder’s invest­ments gene­rally realize growth through inter­na­tio­na­liza­tion, focu­sing of stra­tegy and busi­ness model, exten­sive invest­ments mainly in capa­city expan­sion and stra­te­gic acquisitions.

Parties invol­ved IK Invest­ment Partners:
IK Invest­ment Part­ners: Anders Peters­son, Mirko Jablon­sky, Alex­an­der Dokters, Adrian Tanski, Daniel-Vito Günther
Buyer finan­cial advi­sor: Quar­ton Inter­na­tio­nal (Lars Veit, Rolf Holtmann)
Buyer stra­te­gic due dili­gence: Alva­rez & Marsal (Georg Hochleitner)
Buyer finan­cial due dili­gence: Ebner Stolz (Claus Bähre)
Buyer legal advi­sor: Renzen­brink & Part­ner (Ulf Renzenbrink)

About IK Invest­ment Partners
IKInvest­ment Part­ners is a Euro­pean private equity firm with an invest­ment focus on the Nordic count­ries, the DACH region and France/Benelux. Since 1989, IK has laun­ched funds with a cumu­la­tive equity volume of more than 9.5 billion euros and inves­ted in more than 115 Euro­pean compa­nies. The IK Funds support compa­nies with signi­fi­cant growth poten­tial and their manage­ment teams in deve­lo­ping busi­ness models for the future, streng­thening the compa­nies’ market posi­tion and thus crea­ting outstan­ding long-term deve­lo­p­ment poten­tial. www.ikinvest.com

About KLINGEL medi­cal metal
For more than 30 years, KLINGEL medi­cal metal GmbH has been one of the leading Euro­pean compa­nies in precis­ion tech­no­logy with a stra­te­gic focus on medi­cal tech­no­logy. With more than 300 employees, KLINGEL medi­cal metal GmbH specia­li­zes in the precis­ion machi­ning of diffi­­cult-to-machine mate­ri­als such as tita­nium and stain­less steel. KLINGEL offers unsur­pas­sed tech­ni­cal quality and aesthe­tic perfec­tion. www.klingel-med.de